Search the collection

3 results for Gianni,+Luca,+Prof

Sort by:

Sort by

Limit results to:

20 per page

3 results for Gianni,+Luca,+Prof

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
The immune system and response to HER2-targeted treatment in breast cancer
Author / Creator:Bianchini, Giampaolo, MD ; Gianni, Luca, Prof
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2014-02, Vol.15 (2), p.e58-e68
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 ra...
Author / Creator:Gianni, Luca, Prof ; Pienkowski, Tadeusz, Prof ; Im, Young-Hyuck, Prof ; Tseng, Ling-Ming, MD ; Liu, Mei-Ching, MD ; Lluch, Ana, MD ; Starosławska, Elżbieta, Prof ; de la Haba-Rodriguez, Juan, MD ; Im, Seock-Ah, Prof ; Pedrini, Jose Luiz, MD ; Poirier, Brigitte, MD ; Morandi, Paolo, MD ; Semiglazov, Vladimir, Prof ; Srimuninnimit, Vichien, Prof ; Bianchi, Giulia Valeria, MD ; Magazzù, Domenico, PhD ; McNally, Virginia, PhD ; Douthwaite, Hannah, MSc ; Ross, Graham, FFPM ; Valagussa, Pinuccia, BS
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2016-06, Vol.17 (6), p.791-800
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
Author / Creator:Gianni, Luca, Prof ; Dafni, Urania, Prof ; Gelber, Richard D, Prof ; Azambuja, Evandro, PhD ; Muehlbauer, Susanne, PhD ; Goldhirsch, Aron, Prof ; Untch, Michael, Prof ; Smith, Ian, Prof ; Baselga, José, Prof ; Jackisch, Christian, Prof ; Cameron, David, Prof ; Mano, Max, MD ; Pedrini, José Luiz, MD ; Veronesi, Andrea, Prof ; Mendiola, Cesar, MD ; Pluzanska, Anna, Prof ; Semiglazov, Vladimir, MD ; Vrdoljak, Eduard, MD ; Eckart, Michael J, MD ; Shen, Zhenzhou, Prof ; Skiadopoulos, George, MSci ; Procter, Marion, MSci ; Pritchard, Kathleen I, MD ; Piccart-Gebhart, Martine J, PhD ; Bell, Richard, MBBS
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2011-03, Vol.12 (3), p.236-244
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Export record to excel

Export this record

Export record to excel

The immune system and response to HER2-targeted treatment in breast cancer

Export this record

Export record to excel

5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 ra...

Export this record

Export record to excel

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial

Refine your search